Show simple item record

Induction of hyperproliferative fetal megakaryopoiesis by an N-terminally truncated GATA1 mutant

dc.contributor.authorShimizu, Ritsukoen_US
dc.contributor.authorKobayashi, Erien_US
dc.contributor.authorEngel, James Douglasen_US
dc.contributor.authorYamamoto, Masayukien_US
dc.date.accessioned2010-06-01T22:17:14Z
dc.date.available2010-06-01T22:17:14Z
dc.date.issued2009-09en_US
dc.identifier.citationShimizu, Ritsuko; Kobayashi, Eri; Engel, James Douglas; Yamamoto, Masayuki (2009). "Induction of hyperproliferative fetal megakaryopoiesis by an N-terminally truncated GATA1 mutant." Genes to Cells 14(9): 1119-1131. <http://hdl.handle.net/2027.42/75300>en_US
dc.identifier.issn1356-9597en_US
dc.identifier.issn1365-2443en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/75300
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19682090&dopt=citationen_US
dc.format.extent696057 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rightsJournal compilation © 2009 by the Molecular Biology Society of Japan/Blackwell Publishing Ltden_US
dc.titleInduction of hyperproliferative fetal megakaryopoiesis by an N-terminally truncated GATA1 mutanten_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelGeneticsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI 48109-220, USAen_US
dc.contributor.affiliationotherDepartment of Experimental Hematology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-cho, Aoba-ku, Sendai 980-8575, Japanen_US
dc.contributor.affiliationotherDepartment of Medical Biochemistry, Tohoku University Graduate School of Medicine, 2-1 Seiryo-cho, Aoba-ku, Sendai 980-8575, Japanen_US
dc.identifier.pmid19682090en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/75300/1/j.1365-2443.2009.01338.x.pdf
dc.identifier.doi10.1111/j.1365-2443.2009.01338.xen_US
dc.identifier.sourceGenes to Cellsen_US
dc.identifier.citedreferenceAhmed, M., Sternberg, A., Hall, G., Thomas, A., Smith, O., O’Marcaigh, A., Wynn, R., Stevens, R., Addison, M., King, D., Stewart, B., Gibson, B., Roberts, I. & Vyas, P. ( 2004 ) Natural history of GATA1 mutations in Down syndrome. Blood 103, 2480 – 2489.en_US
dc.identifier.citedreferenceBozner, P. ( 2002 ) Transient myeloproliferative disorder with erythroid differentiation in Down syndrome. Arch. Pathol. Lab. Med. 126, 474 – 477.en_US
dc.identifier.citedreferenceCalligaris, R., Bottardi, S., Cogoi, S., Apezteguia, I. & Santoro, C. ( 1995 ) Alternative translation initiation site usage results in two functionally distinct forms of the GATA-1 transcription factor. Proc. Natl Acad. Sci. USA 92, 11598 – 11602.en_US
dc.identifier.citedreferenceChang, A.N., Cantor, A.B., Fujiwara, Y., Lodish, M.B., Droho, S., Crispino, J.D. & Orkin, S.H. ( 2002 ) GATA-factor dependence of the multitype zinc-finger protein FOG-1 for its essential role in megakaryopoiesis. Proc. Natl Acad. Sci. USA 14, 9237 – 9242.en_US
dc.identifier.citedreferenceDubart, A., Romeo, P.H., Vainchenker, W. & Dumenil, D. ( 1996 ) Constitutive expression of GATA-1 interferes with the cell-cycle regulation. Blood 87, 3711 – 3721.en_US
dc.identifier.citedreferenceFujiwara, Y., Browne, C.P., Cunniff, K., Goff, S.C. & Orkin, S.H. ( 1996 ) Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc. Natl Acad. Sci. USA 93, 12355 – 12358.en_US
dc.identifier.citedreferenceGreene, M.E., Mundschau, G., Wechsler, J., McDevitt, M., Gamis, A., Karp, J., Gurbuxani, S., Arceci, R. & Crispino, J.D. ( 2003 ) Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome. Blood Cells Mol. Dis. 31, 351 – 356.en_US
dc.identifier.citedreferenceHarigae, H., Xu, G., Sugawara, T., Ishikawa, I., Toki, T. & Ito, E. ( 2004 ) The GATA1 mutation in an adult patient with acute megakaryoblastic leukemia not accompanying Down syndrome. Blood 103, 3242 – 3243.en_US
dc.identifier.citedreferenceHitzler, J.K., Cheung, J., Li, Y., Scherer, S.W. & Zipursky, A. ( 2003 ) GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. Blood 101, 4301 – 4304.en_US
dc.identifier.citedreferenceHollanda, L.M., Lima, C.S., Cunha, A.F., Albuquerque, D.M., Vassallo, J., Ozelo, M.C., Joazeiro, P.P., Saad, S.T. & Costa, F.F. ( 2006 ) An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis. Nat. Genet. 18, 807 – 812.en_US
dc.identifier.citedreferenceHolmes, D.K., Bates, N., Murray, M., Ladusans, E.J., Morabito, A., Bolton-Maggs, P.H., Johnston, T.A., Walkenshaw, S., Wynn, R.F. & Bellantuono, I. ( 2006 ) Hematopoietic progenitor cell deficiency in fetuses and children affected by Down’s syndrome. Exp. Hematol. 34, 1611 – 1615.en_US
dc.identifier.citedreferenceIto, E., Kasai, M., Hayashi, Y., Toki, T., Arai, K., Yokoyama, S., Kato, K., Tachibana, N., Yamamoto, M. & Yokoyama, M. ( 1995 ) Expression of erythroid-specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down’s syndrome. Br. J. Haematol. 90, 607 – 614.en_US
dc.identifier.citedreferenceIto, E., Toki, T., Ishihara, H., Ohtani, H., Gu, L., Yokoyama, M., Engel, J.D. & Yamamoto, M. ( 1993 ) Erythroid transcription factor GATA-1 is abundantly transcribed in mouse testis. Nature 362, 466 – 468.en_US
dc.identifier.citedreferenceKarandikar, N.J., Aquino, D.B., McKenna, R.W. & Kroft, S.H. ( 2001 ) Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis. Am. J. Clin. Pathol. 116, 204 – 210.en_US
dc.identifier.citedreferenceKaushansky, K. ( 1995 ) Thrombopoietin: the primary regulator of platelet production. Blood 86, 419 – 431.en_US
dc.identifier.citedreferenceKuhl, C., Atzberger, A., Iborra, F., Nieswandt, B., Porcher, C. & Vyas, P. ( 2005 ) GATA1-mediated megakaryocyte differentiation and growth control can be uncoupled and mapped to different domains in GATA1. Mol. Cell. Biol. 25, 8592 – 8606.en_US
dc.identifier.citedreferenceLevine, R.F. & Fedorko, M.E. ( 1976 ) Isolation of intact megakaryocytes from guinea pig femoral marrow. Successful harvest made possible with inhibitions of platelet aggregation; enrichment achieved with a two-step separation technique. J. Cell Biol. 69, 159 – 172.en_US
dc.identifier.citedreferenceLi, Z., Godinho, F.J., Klusmann, J.H., Garriga-Canut, M., Yu, C. & Orkin, S.H. ( 2005 ) Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1. Nat. Genet. 37, 613 – 619.en_US
dc.identifier.citedreferenceMassey, G.V. ( 2005 ) Transient leukemia in newborns with Down syndrome. Pediatr. Blood Cancer 44, 29 – 32.en_US
dc.identifier.citedreferenceNishimura, S., Takahashi, S., Kuroha, T., Suwabe, N., Nagasawa, T., Trainor, C. & Yamamoto, M. ( 2000 ) A GATA box in the GATA-1 gene hematopoietic enhancer is a critical element in the network of GATA factors and sites that regulate this gene. Mol. Cell. Biol. 20, 713 – 723.en_US
dc.identifier.citedreferenceOnodera, K., Takahashi, S., Nishimura, S., Ohta, J., Motohashi, H., Yomogida, K., Hayashi, N., Engel, J.D. & Yamamoto, M. ( 1997 ) GATA-1 transcription is controlled by distinct regulatory mechanisms during primitive and definitive erythropoiesis. Proc. Natl Acad. Sci. USA 94, 4487 – 4492.en_US
dc.identifier.citedreferencePan, X., Ohneda, O., Ohneda, K., Lindeboom, F., Iwata, F., Shimizu, R., Nagano, M., Suwabe, N., Philipsen, S., Lim, K.C., Engel, J.D. & Yamamoto, M. ( 2005 ) Graded levels of GATA-1 expression modulate survival, proliferation and differentiation of erythroid progenitors. J. Biol. Chem. 6, 22385 – 22394.en_US
dc.identifier.citedreferenceRainis, L., Bercovich, D., Strehl, S., Teigler-Schlegel, A., Stark, B., Trka, J., Amariglio, N., Biondi, A., Muler, I., Rechavi, G., Kempski, H., Haas, O.A. & Izraeli, S. ( 2003 ) Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. Blood 102, 981 – 986.en_US
dc.identifier.citedreferenceShimizu, R., Engel, J.D. & Yamamoto, M. ( 2008 ) GATA1-related leukaemias. Nat. Rev. Cancer 8, 279 – 287.en_US
dc.identifier.citedreferenceShimizu, R., Kuroha, T., Ohneda, O., Pan, X., Ohneda, K., Takahashi, S., Philipsen, S. & Yamamoto, M. ( 2004a ) Leukemogenesis caused by incapacitated GATA-1 function. Mol. Cell. Biol. 24, 10814 – 10825.en_US
dc.identifier.citedreferenceShimizu, R., Ohneda, K., Engel, J.D., Trainor, C.D. & Yamamoto, M. ( 2004b ) Transgenic rescue of GATA-1-deficient mice with GATA-1 lacking a FOG-1 association site phenocopies patients with X-linked thrombocytopenia. Blood 103, 2560 – 2567.en_US
dc.identifier.citedreferenceShimizu, R., Takahashi, S., Ohneda, K., Engel, J.D. & Yamamoto, M. ( 2001 ) In vivo requirements for GATA-1 functional domains during primitive and definitive erythropoiesis. EMBO J. 20, 5250 – 5260.en_US
dc.identifier.citedreferenceTakahashi, S., Onodera, K., Motohashi, H., Suwabe, N., Hayashi, N., Yanai, N., Nabesima, Y. & Yamamoto, M. ( 1997 ) Arrest in primitive erythroid cell development caused by promoter-specific disruption of the GATA-1 gene. J. Biol. Chem. 272, 12611 – 12615.en_US
dc.identifier.citedreferenceTober, J., Koniski, A., McGrath, K.E., Vemishetti, R., Emerson, R., de Mesy-Bentley, K.K., Waugh, R. & Palis, J. ( 2007 ) The megakaryocyte lineage originates from hemangioblast precursors and is an integral component both of primitive and of definitive hematopoiesis. Blood 109, 1433 – 1441.en_US
dc.identifier.citedreferenceUgazio, A.G., Maccario, R., Notarangelo, L.D. & Burgio, G.R. ( 1990 ) Immunology of Down syndrome: a review. Am. J. Med. Genet. Suppl. 7, 204 – 212.en_US
dc.identifier.citedreferenceVannucchi, A.M., Bianchi, L., Cellai, C., Paoletti, F., Rana, R.A., Lorenzini, R., Migliaccio, G. & Migliaccio, A.R. ( 2002 ) Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice). Blood 100, 1123 – 1132.en_US
dc.identifier.citedreferenceWechsler, J., Greene, M., McDevitt, M.A., Anastasi, J., Karp, J.E., Le Beau, M.M. & Crispino, J.D. ( 2002 ) Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat. Genet. 12, 1 – 5.en_US
dc.identifier.citedreferenceWeiss, M.J. & Orkin, S.H. ( 1995 ) Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc. Natl Acad. Sci. USA 92, 9623 – 9627.en_US
dc.identifier.citedreferenceXu, M.J., Matsuoka, S., Yang, F.C., Ebihara, Y., Manabe, A., Tanaka, R., Eguchi, M., Asano, S., Nakahata, T. & Tsuji, K. ( 2001 ) Evidence for the presence of murine primitive megakaryocytopoiesis in the early yolk sac. Blood 97, 2016 – 2022.en_US
dc.identifier.citedreferenceZipursky, A. ( 2003 ) Transient leukaemia – a benign form of leukaemia in newborn infants with trisomy 21. Br. J. Haematol. 120, 930 – 938.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.